Genenta raises EUR7M in series B

Gene therapy company Genenta Science s.r.l. (Milan, Italy) said it raised €7 million ($8.4 million) on Sept. 13 in a series B round with participation from undisclosed private and series A investors; family offices, including Rovati, Ferragamo, and past investor Marzotto; angel investors, including Club degli Investitori; and company board members.

Chairman and CEO Pierluigi Paracchi told BioCentury the funding will support opening a second tumor indication program. Paracchi said Genenta expects to start clinical testing of its first program to treat multiple myeloma in the first part of 2018...